Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.
Illumina Casava1.7 software used for basecalling.

T2 hyperintense; FLAIR high signal; contrast enhancement (recurrence)
Heterogeneous lesions with subtle diffusion restriction; extensive peri-tumor edema
T2 hyperintense; contrast enhancement (recurrence)
Contrast enhancement - post surgical change
T2 - hyperintense; T1 heterogenous intensity; contrast enhancing
T2 hyperintense; central restricted diffusion; rim enhancing
T2 hyperintense; T1 hypointense; rim enhancing lesion
T2 hyperintense; FLAIR high signal; contrast enhancement
Rim enhancing lesion
Rim enhancing lesion with central restricted diffusion
Rim enhancing lesion with central restricted diffusion
Heterogenously enhancing mass
High FLAIR signal
T2 - hyperintense; T1 hypointense; rim peripheral restricted diffusion
T2 - hyperintense; FLAIR - high signal; no contrast enhancement (recurrence)
T2 - hyperintense; FLAIR - patchy suppression
T2 - hyperintense; T1 - isointense; no contrast enhancement (recurrence)
T1 - hyperintense; contrast enhancing (recurrence)
Contrast enhancement; central diffusion restriction
T2 hyperintense; contrast enhancement (recurrence)
T2 hyperintense; contrast enhancement anteriorly
T2 hyperintensity; FLAIR high signal; contrast enhancement (recurrence)

Treatment effects (tumour necrosis with mineralisation and hyalinised vessels)